BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 20527061)

  • 1. Prophylactic platelet transfusions.
    Valeri CR; Ragno GM
    N Engl J Med; 2010 Jun; 362(22):2141; author reply 2141-2. PubMed ID: 20527061
    [No Abstract]   [Full Text] [Related]  

  • 2. Prophylactic platelet transfusions.
    Estcourt LJ; Stanworth SJ; Murphy MF
    Curr Opin Hematol; 2010 Sep; 17(5):411-7. PubMed ID: 20601869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red blood cell and platelet transfusions in the treatment of anemic thrombocytopenic patients.
    Valeri CR; Ragno G
    Transfusion; 2006 Dec; 46(12):2210-1; author reply 2211-2. PubMed ID: 17176338
    [No Abstract]   [Full Text] [Related]  

  • 4. A consistent approach to platelet transfusion in the NICU.
    Del Vecchio A; Motta M; Radicioni M; Christensen RD
    J Matern Fetal Neonatal Med; 2012 Oct; 25(Suppl 5):93-6. PubMed ID: 23025779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventions to reduce platelet prophylactic transfusions in patients with hypoproliferative thrombocytopenia: providing patients with the full benefit.
    Vamvakas EC; Hitzler WE
    Clin Lab; 2013; 59(5-6):459-64. PubMed ID: 23865342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic platelet transfusions.
    Focosi D
    N Engl J Med; 2010 Jun; 362(22):2140-1; author reply 2141-2. PubMed ID: 20527081
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelets photochemically treated with amotosalen HCl and ultraviolet A light correct prolonged bleeding times in patients with thrombocytopenia.
    Slichter SJ; Raife TJ; Davis K; Rheinschmidt M; Buchholz DH; Corash L; Conlan MG
    Transfusion; 2006 May; 46(5):731-40. PubMed ID: 16686840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Indications for transfusions of labile blood products].
    Wautier JL
    Transfus Clin Biol; 2005 Feb; 12(1):56-8. PubMed ID: 15814294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients.
    Slichter SJ
    J Clin Apher; 2006 Apr; 21(1):78-84. PubMed ID: 16619231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic platelet transfusion threshold during therapy for adult acute myeloid leukemia: 10,000/microL versus 20,000/microL.
    Navarro JT; Hernández JA; Ribera JM; Sancho JM; Oriol A; Pujol M; Millá F; Feliu E
    Haematologica; 1998 Nov; 83(11):998-1000. PubMed ID: 9864920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. POLYMORPHISM OF COLLECTION, TRANSFUSION AND EFFECTIVENESS OF DONOR PLATELETS CONCENTRATES.
    Gubanova MN; Ayupova RF; Zhiburt EB
    Anesteziol Reanimatol; 2017 Jan; 62(1):77-79. PubMed ID: 29932588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing platelet transfusion therapy.
    Heal JM; Blumberg N
    Blood Rev; 2004 Sep; 18(3):149-65. PubMed ID: 15183900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical aspects of treatment with platelet concentrates.
    Lanzer G
    Acta Anaesthesiol Scand Suppl; 1996; 109():141-3. PubMed ID: 8901986
    [No Abstract]   [Full Text] [Related]  

  • 14. New thoughts on the correct dosing of prophylactic platelet transfusions to prevent bleeding.
    Slichter SJ
    Curr Opin Hematol; 2011 Nov; 18(6):427-35. PubMed ID: 21946073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of platelets in transfusion medicine.
    Brubaker DB
    J Am Osteopath Assoc; 1989 Dec; 89(12):1553-9. PubMed ID: 2621122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet transfusion prophylaxis for patients with haematological malignancies: where to now?
    Stanworth SJ; Hyde C; Brunskill S; Murphy MF
    Br J Haematol; 2005 Dec; 131(5):588-95. PubMed ID: 16351634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different Platelet Count Thresholds to Guide Use of Prophylactic Platelet Transfusions for Patients With Hematological Disorders After Myelosuppressive Chemotherapy or Stem Cell Transplantation.
    Estcourt LJ; Stanworth SJ; Murphy MF
    JAMA Oncol; 2016 Aug; 2(8):1091-2. PubMed ID: 27415031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of in vitro adult platelet transfusions on neonatal hemostasis.
    Ferrer-Marin F; Chavda C; Lampa M; Michelson AD; Frelinger AL; Sola-Visner M
    J Thromb Haemost; 2011 May; 9(5):1020-8. PubMed ID: 21320282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses.
    Arnold DM; Crowther MA; Cook RJ; Sigouin C; Heddle NM; Molnar L; Cook DJ
    Transfusion; 2006 Aug; 46(8):1286-91. PubMed ID: 16934061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic platelet transfusions.
    Cid J; Escolar G; Lozano M
    N Engl J Med; 2010 Jun; 362(22):2140; author reply 2141-2. PubMed ID: 20519690
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.